Evaluation of the Relationship Between Zinc Vitamin D and b12 Levels in the Covid-19 Positive Pregnant Women
Zinc Vitamin D and b12 Levels in the Covid-19 Positive Pregnant Women
1 other identifier
observational
44
1 country
1
Brief Summary
Zinc d vitamin and b12 serum levels in covid-19 positive pregnants will be compared in terms of patients' responses to computed tomography and treatment.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Apr 2020
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 20, 2020
CompletedFirst Submitted
Initial submission to the registry
May 27, 2020
CompletedFirst Posted
Study publicly available on registry
May 29, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
June 14, 2020
CompletedJune 23, 2020
June 1, 2020
1 month
May 27, 2020
June 19, 2020
Conditions
Outcome Measures
Primary Outcomes (1)
Serum zinc, vitamin d vitamin b12 deficiency levels
Serum zinc, vitamin d vitamin b12 levels of 45 patients will be measured and evaluated together with the information of the patients.
2 months
Interventions
Serum zinc, vitamin d vitamin b12 levels of 45 patients will be measured and evaluated together with the information of the patients.
Eligibility Criteria
Pregnant women between 18-45 years old with positive covid-19 pcr test results
You may qualify if:
- covid-19 positive pregnant women
- under 18 or more than 45 years old
You may not qualify if:
- vitamin D , Vitamin B12 or Zinc supplement use
- Multivitamine use
- have taken vitamin supplements in the past 3 months
- use of medicines for vitamin deficiency
- having metabolic disease covid-19 negative pregnant women
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Kanuni Sultan Suleyman Training and Research Hospitallead
- Ayşegül Bestelcollaborator
- İbrahim Polatcollaborator
- Merve Aldıkaçtıoğlu Talmaçcollaborator
Study Sites (1)
Pinar Yalcin Bahat
Istanbul, İ̇stanbul, 34000, Turkey (Türkiye)
Biospecimen
Serum zinc, vitamin d vitamin b12 levels
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
May 27, 2020
First Posted
May 29, 2020
Study Start
April 20, 2020
Primary Completion
June 1, 2020
Study Completion
June 14, 2020
Last Updated
June 23, 2020
Record last verified: 2020-06
Data Sharing
- IPD Sharing
- Will share